AN2 Therapeutics, Inc. Quarterly Common Stock, Shares, Issued from Q4 2021 to Q4 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
AN2 Therapeutics, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2021 to Q4 2024.
  • AN2 Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending December 31, 2024 was 29.9M shares, a 0.6% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 29.9M +178K +0.6% Dec 31, 2024 10-K 2025-03-25
Q3 2024 29.9M +127K +0.43% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 29.8M +7.9M +36% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 29.8M +10.4M +53.5% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 29.7M +10.3M +53.3% Dec 31, 2023 10-K 2025-03-25
Q3 2023 29.7M +10.3M +53.3% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 21.9M +2.53M +13% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 19.4M +714K +3.81% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 19.4M +16.7M +611% Dec 31, 2022 10-K 2024-03-29
Q3 2022 19.4M Sep 30, 2022 10-Q 2022-11-09
Q2 2022 19.4M Jun 30, 2022 10-Q 2022-08-11
Q1 2022 18.7M Mar 31, 2022 10-Q 2022-05-10
Q4 2021 2.73M Dec 31, 2021 10-K 2023-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.